Toronto Dominion Bank’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-10
| Closed | – | – | 1463 |
|
2022
Q2 | $0 | Buy |
+10
| New | – | ﹤0.01% | 1958 |
|
2022
Q1 | – | Sell |
-14
| Closed | – | – | 2059 |
|
2021
Q4 | $0 | Buy |
+14
| New | – | ﹤0.01% | 2064 |
|
2021
Q3 | – | Sell |
-10
| Closed | – | – | 1486 |
|
2021
Q2 | $0 | Buy |
+10
| New | – | ﹤0.01% | 1489 |
|
2021
Q1 | – | Sell |
-4
| Closed | – | – | 1527 |
|
2020
Q4 | $0 | Buy |
+4
| New | – | ﹤0.01% | 1379 |
|
2019
Q4 | – | Sell |
-2
| Closed | – | – | 1229 |
|
2019
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 1277 |
|
2019
Q2 | – | Sell |
-1
| Closed | – | – | 1333 |
|
2019
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1279 |
|
2018
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1253 |
|
2018
Q3 | – | Sell |
-2
| Closed | – | – | 1215 |
|
2018
Q2 | $0 | Buy |
2
+1
| +100% | – | ﹤0.01% | 1204 |
|
2018
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1112 |
|
2017
Q4 | – | Sell |
-2
| Closed | – | – | 1077 |
|
2017
Q3 | $0 | Sell |
2
-2
| -50% | – | ﹤0.01% | 1059 |
|
2017
Q2 | $0 | Buy |
4
+3
| +300% | – | ﹤0.01% | 1086 |
|
2017
Q1 | $0 | Sell |
1
-5
| -83% | – | ﹤0.01% | 1086 |
|
2016
Q4 | $0 | Buy |
6
+5
| +500% | – | ﹤0.01% | 1100 |
|
2016
Q3 | $0 | Sell |
1
-12
| -92% | – | ﹤0.01% | 1039 |
|
2016
Q2 | $1K | Buy |
13
+9
| +225% | +$692 | ﹤0.01% | 972 |
|
2016
Q1 | $0 | Buy |
+4
| New | – | ﹤0.01% | 1058 |
|
2015
Q3 | – | Sell |
-1
| Closed | – | – | 897 |
|
2015
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 922 |
|
2015
Q1 | – | Sell |
-1
| Closed | – | – | 903 |
|
2014
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 897 |
|
2014
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 856 |
|
2014
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 884 |
|
2014
Q1 | $1K | Sell |
1
-1
| -50% | -$1K | ﹤0.01% | 832 |
|
2013
Q4 | $1K | Hold |
2
| – | – | ﹤0.01% | 835 |
|
2013
Q3 | $2K | Hold |
2
| – | – | ﹤0.01% | 577 |
|
2013
Q2 | $2K | Buy |
+2
| New | +$2K | ﹤0.01% | 593 |
|